These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 32119915)
1. Long non-coding RNA MALAT1 as a key target in pathogenesis of glioblastoma. Janus faces or Achilles' heal? Baspinar Y; Elmaci I; Ozpinar A; Altinoz MA Gene; 2020 May; 739():144518. PubMed ID: 32119915 [TBL] [Abstract][Full Text] [Related]
2. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma. Cai T; Liu Y; Xiao J Cancer Med; 2018 Apr; 7(4):1404-1415. PubMed ID: 29479863 [TBL] [Abstract][Full Text] [Related]
4. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
5. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181 [TBL] [Abstract][Full Text] [Related]
6. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802 [TBL] [Abstract][Full Text] [Related]
8. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma. Voce DJ; Bernal GM; Wu L; Crawley CD; Zhang W; Mansour NM; Cahill KE; Szymura SJ; Uppal A; Raleigh DR; Spretz R; Nunez L; Larsen G; Khodarev NN; Weichselbaum RR; Yamini B Cancer Res; 2019 May; 79(10):2536-2548. PubMed ID: 30940658 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780 [TBL] [Abstract][Full Text] [Related]
10. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 protects cardiomyocytes from isoproterenol-induced apoptosis through sponging miR-558 to enhance ULK1-mediated protective autophagy. Guo X; Wu X; Han Y; Tian E; Cheng J J Cell Physiol; 2019 Jul; 234(7):10842-10854. PubMed ID: 30536615 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines. Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
14. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101. Li Z; Xu C; Ding B; Gao M; Wei X; Ji N J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis. Chang SM; Hu WW J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115 [TBL] [Abstract][Full Text] [Related]
17. LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth. Wang H; Hu Q; Tong Y; Li S; Chen M; Wang B; Li H Cell Cycle; 2021 Oct; 20(19):2010-2020. PubMed ID: 34470582 [TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide. Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966 [TBL] [Abstract][Full Text] [Related]
19. The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway. Li S; Sun Y; Zhong L; Xiao Z; Yang M; Chen M; Wang C; Xie X; Chen X Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1175-1187. PubMed ID: 30314869 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MALAT1 promotes osterix expression to regulate osteogenic differentiation by targeting miRNA-143 in human bone marrow-derived mesenchymal stem cells. Gao Y; Xiao F; Wang C; Wang C; Cui P; Zhang X; Chen X J Cell Biochem; 2018 Aug; 119(8):6986-6996. PubMed ID: 29741283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]